Legislation We’re Watching: Improving Alzheimer’s Access and Care

As the policy landscape around Alzheimer’s disease evolves, several proposals in Congress aim to address the needs of people living with Alzheimer’s and those who care for them, focusing on improving access to diagnostic tools, ensuring timely access to treatments, and strengthening support for the care workforce and caregivers. As momentum builds, we are keeping a close eye on how these efforts may shape care and access:

ASAP Act

Early and accurate diagnosis can make a huge difference in managing Alzheimer’s. The Alzheimer’s Screening and Prevention Act (ASAP Act), introduced in mid-November, aims to expand Medicare coverage for diagnostic tools, including blood tests and cognitive assessments. By making these tools more accessible, the bill helps individuals and families detect Alzheimer’s earlier, plan for care, and access treatments sooner. The legislation has bipartisan support and is backed by leading advocacy organizations, including the Alzheimer’s Association.

Cognitive Screening Bill S. 1799

Routine cognitive assessments are critical for early detection of Alzheimer’s. Cognitive Screening Bill S. 1799 focuses on integrating these assessments into regular healthcare visits, helping families and healthcare providers identify changes early and connect patients with support services. Early detection empowers families to make informed decisions and access appropriate care.

Support for the Workforce/Caregivers: ADDAPT Act

The Alzheimer’s care community relies heavily on family caregivers and a professional workforce that is already stretched thin. The ADDAPT Act aims to expand training, support, and programs for direct care workers. This act seeks to enhance the stability and quality of care. Increasing investment in the care workforce can help reduce burnout among caregivers and improve continuity of support for families navigating the disease.

As Congress considers these proposals, the central focus remains on supporting those living with Alzheimer’s, lowering costs, and ensuring policies keep pace with science.  We will continue to monitor these developments and share updates as more information becomes available. Learn more about policy solutions here.